Valuation : Cipher Pharmaceuticals Inc.

Market Cap 35Cr 26Cr 22Cr 21Cr 19Cr 2.44TCr 36Cr 244.6Cr 95Cr 1.23TCr 96Cr 94Cr 4.08TCr P/E 2026 *
12.4x
P/E 2027 * 11.2x
Enterprise Value 35Cr 26Cr 22Cr 21Cr 19Cr 2.44TCr 36Cr 244.6Cr 95Cr 1.23TCr 96Cr 94Cr 4.08TCr EV / Sales 2026 *
5x
EV / Sales 2027 * 4.29x
Free-Float
57.65%
Yield 2026 *
-
Yield 2027 * -
1 day-1.48%
1 week-1.06%
Current month-17.11%
1 month-14.47%
3 months-15.51%
6 months-7.06%
Current year-7.37%
1 week 13.95
Extreme 13.95
14.31
1 month 13.51
Extreme 13.51
18.46
Current year 13.51
Extreme 13.51
20.56
1 year 12.48
Extreme 12.48
20.56
3 years 3.9
Extreme 3.9
20.56
5 years 1.54
Extreme 1.54
20.56
10 years 0.38
Extreme 0.38
20.56
Manager TitleAgeSince
Chief Executive Officer - 29/07/2019
Director of Finance/CFO - 10/08/2024
Director of Finance/CFO - 15/08/2022
Director TitleAgeSince
Chairman - 12/06/2019
Director/Board Member 78 21/06/2023
Director/Board Member - 21/06/2023
Date Insider Type Main position Quantity % Market Cap.
24/06/26 Option

Director

2,500 0.0098%
27/03/26 Option

Chief Executive Officer

83,902 0.3307%
27/03/26 Option

Chief Executive Officer

83,902 0.3307%
Change 5-day change 1-year change 3-year change Capi.($)
-1.48%-1.06%-10.81%+240.24% 26Cr
-0.13%-6.44%+60.47%+112.05% 1,04700Cr
+0.85%-0.81%+52.77%+63.15% 65TCr
-1.03%-3.58%+22.87%+73.29% 45TCr
-1.46%-4.50%+37.43%+38.41% 35TCr
-0.72%-2.89%+21.86%+36.79% 29TCr
-1.19%-2.21%+1.35%+12.29% 25TCr
-1.05%-1.57%+51.40%+68.55% 23TCr
+0.08%-1.78%-17.64%-54.29% 20TCr
-2.14%-0.30%+29.42%+89.10% 18TCr
Average -0.84%-2.51%+24.92%+67.96% 36.6TCr
Weighted average by Cap. -0.48%-3.46%+38.66%+65.53%

Financials

2026 *2027 *
Net sales 7.09Cr 5.1Cr 4.4Cr 4.12Cr 3.76Cr 487.55Cr 7.11Cr 49Cr 19Cr 246.11Cr 19Cr 19Cr 816.07Cr 8.27Cr 5.95Cr 5.13Cr 4.81Cr 4.39Cr 568.84Cr 8.3Cr 57Cr 22Cr 287.14Cr 22Cr 22Cr 952.12Cr
Net income 2.76Cr 1.99Cr 1.71Cr 1.6Cr 1.46Cr 189.77Cr 2.77Cr 19Cr 7.43Cr 96Cr 7.46Cr 7.29Cr 317.65Cr 3.25Cr 2.34Cr 2.02Cr 1.89Cr 1.72Cr 223.5Cr 3.26Cr 22Cr 8.75Cr 112.82Cr 8.78Cr 8.59Cr 374.11Cr
Net Debt - -
Logo Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals Inc. is a Canada-based specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products. The Company acquires products, manages the required clinical development and regulatory approval process, and markets those products either directly or indirectly in Canada, the United States and South America. The Company's product categories include dermatology, hospital acute care, out‑licensed, and specialty medicine. Its dermatology products include Actikerall, Epuris, Vaniqa and Natroba. Its hospital acute care products include Aggrastat and Brinavess. Its out-licensed products include Absorica, ConZip and Lipofen. Absorica (isotretinoin) is an oral retinoid. Durela, its specialty medicine, is an opioid analgesic indicated for the management of moderate to moderately severe pain in adults who require continuous treatment for several days or more. Its pipeline products include Piclidenoson CF-101, MOB-015 and DTR-001.
Employees
5
Date Price Change Volume
28/26/28 CA$13.95 -1.48% 55,238
27/26/27 CA$14.16 +0.43% 16,875
26/26/26 CA$14.10 -0.42% 24,400
25/26/25 CA$14.16 +0.43% 29,275
24/26/24 CA$14.10 0.00% 85,694
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
13.95CAD
Average target price
19.95CAD
Spread / Average Target
+43.01%

Quarterly revenue - Rate of surprise